10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
13.12
+0.08 (0.61%)
Sep 22, 2025, 3:31 PM EDT - Market open
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $1.63 billion as of September 22, 2025. Its market cap has decreased by -40.73% in one year.
Market Cap
1.63B
Enterprise Value
1.27B
1-Year Change
-40.73%
Ranking
Category
Stock Price
$13.12
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $1.63B, a decrease of -67.01%. That is a compound annual growth rate of -16.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 1.62B | -6.61% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | 15.24B | 107.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.09B |
| Johnson & Johnson | 424.33B |
| AbbVie | 393.01B |
| UnitedHealth Group | 304.93B |
| Novo Nordisk | 271.64B |
| Novartis AG | 237.99B |
| Abbott Laboratories | 236.77B |
| AstraZeneca | 236.24B |